drugset / Trial / NCT07479719

Anesthesia Maintenance With Target-controlled Infusion of Propofol and Remifentanil at Fixed Ratio

NCT07479719

Phase 4 Not yet recruiting 200 enrolled Peking University First Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The impact of anesthesia depths on early postoperative neurocognitive complications after total intravenous anesthesia (TIVA) remains controversial. In some studies investigating TIVA, anesthesiologists mainly achieve the target depth of anesthesia by adjusting the dose of propofol, whereas the doses of opioids remains comparable between different anesthetic depth groups, possibly resulting inadequate analgesia. This study is aimed to investigate the impact of different anesthesia depths maintained by target-controlled infusion of propofol and remifentanil at a fixed ratio on the incidence of early postoperative neurocognitive complications in older patients undergoing noncardiac surgery.

Timeline

Start
2026-04
Primary completion
2027-01
Completion
2027-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule Intravenous
Comparator Remifentanil Small molecule Intravenous

Indications

No indication recorded.